MX362186B - Proceso de sintesis de opioides mejorado. - Google Patents
Proceso de sintesis de opioides mejorado.Info
- Publication number
- MX362186B MX362186B MX2015000880A MX2015000880A MX362186B MX 362186 B MX362186 B MX 362186B MX 2015000880 A MX2015000880 A MX 2015000880A MX 2015000880 A MX2015000880 A MX 2015000880A MX 362186 B MX362186 B MX 362186B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- compounds
- apis
- preparation
- improved opioid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Compuestos y composiciones para el uso como materiales de partida o materiales intermediarios en la preparación de opioides incluyendo, por ejemplo, base de oxicodona y/o una sal de oxicodona; procesos para preparar estos compuestos y composiciones; usos de estos compuestos y composiciones en la preparación de APIs y formas de dosis farmacéuticas; y usos de dichas APIs y formas de dosis farmacéuticas en el tratamiento de condiciones médicas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672265P | 2012-07-16 | 2012-07-16 | |
US201361762657P | 2013-02-08 | 2013-02-08 | |
PCT/IB2013/001538 WO2014013311A1 (en) | 2012-07-16 | 2013-07-15 | Process for improved opioid synthesis |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015000880A MX2015000880A (es) | 2016-09-07 |
MX362186B true MX362186B (es) | 2019-01-08 |
Family
ID=48916126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015000880A MX362186B (es) | 2012-07-16 | 2013-07-15 | Proceso de sintesis de opioides mejorado. |
Country Status (22)
Country | Link |
---|---|
US (4) | US20150259355A1 (es) |
EP (1) | EP2877473B1 (es) |
JP (1) | JP6236446B2 (es) |
KR (1) | KR101946104B1 (es) |
CN (1) | CN104507947B (es) |
AR (1) | AR091779A1 (es) |
AU (2) | AU2013291723B2 (es) |
BR (1) | BR112015000867A2 (es) |
CA (1) | CA2879268C (es) |
CO (1) | CO7180189A2 (es) |
EA (1) | EA029925B1 (es) |
ES (1) | ES2638178T3 (es) |
HK (1) | HK1210171A1 (es) |
IL (1) | IL236711B (es) |
IN (1) | IN2015DN01164A (es) |
MX (1) | MX362186B (es) |
NZ (2) | NZ628695A (es) |
PH (1) | PH12015500088B1 (es) |
SG (1) | SG11201407986QA (es) |
TW (2) | TW201639855A (es) |
UA (1) | UA117226C2 (es) |
WO (1) | WO2014013311A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013291723B2 (en) | 2012-07-16 | 2016-07-28 | Rhodes Technologies | Process for improved opioid synthesis |
CA2879270C (en) * | 2012-07-16 | 2017-09-05 | Rhodes Technologies | Process for improved opioid synthesis |
US10227354B2 (en) | 2013-12-18 | 2019-03-12 | Cody Laboratories, Inc. | Conversion of oxycodone base to oxycodone hydrochloride |
US9062062B1 (en) | 2013-12-18 | 2015-06-23 | Cody Laboratories, Inc. | Synthesis of oxycodone hydrochloride |
US8846923B1 (en) | 2013-12-18 | 2014-09-30 | Cody Laboratories, Inc. | Preparation of 14-hydroxycodeinone sulfate |
WO2015095585A2 (en) | 2013-12-18 | 2015-06-25 | Cody Laboratories, Inc. | Sysnthesis of oxycodone hydrochloride |
KR101868724B1 (ko) | 2014-01-15 | 2018-06-18 | 로드스 테크놀로지즈 | 개선된 옥시모르폰 합성을 위한 방법 |
AU2015207733A1 (en) | 2014-01-15 | 2016-07-14 | Rhodes Technologies | Process for improved oxycodone synthesis |
US20160052932A1 (en) | 2014-08-25 | 2016-02-25 | Johnson Matthey Public Limited Company | Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone |
EP3642207B1 (en) | 2017-06-20 | 2022-08-31 | Johnson Matthey Public Limited Company | Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone |
KR102120720B1 (ko) * | 2018-07-16 | 2020-06-10 | 연성정밀화학(주) | 날푸라핀 함유 구강붕해정 |
CN114573508A (zh) * | 2020-12-01 | 2022-06-03 | 中国科学院上海有机化学研究所 | 羟考酮类化合物、其中间体及制备方法 |
US11247999B1 (en) | 2021-07-02 | 2022-02-15 | Joseph DeGraw | Facile conversion of morphine to normorphine |
CN114276358B (zh) * | 2022-01-07 | 2023-09-12 | 北京华素制药股份有限公司 | 羟考酮盐酸盐的多晶型物及其制备方法和用途 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2772270A (en) | 1954-10-21 | 1956-11-27 | M J Lewenstein | 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone |
US3173876A (en) | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
NL271831A (es) | 1960-11-29 | |||
US3276586A (en) | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
NL6714885A (es) | 1967-11-02 | 1969-05-06 | ||
US3541006A (en) | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
US3541005A (en) | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
GB1478759A (en) | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4063064A (en) | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4200098A (en) | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4285987A (en) | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4861598A (en) | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
DE3812567A1 (de) | 1988-04-15 | 1989-10-26 | Basf Ag | Verfahren zur herstellung pharmazeutischer mischungen |
US5215758A (en) | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
US5286493A (en) | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5273760A (en) | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5472712A (en) | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5324351A (en) | 1992-08-13 | 1994-06-28 | Euroceltique | Aqueous dispersions of zein and preparation thereof |
AU2002316738B2 (en) * | 2001-07-18 | 2009-01-08 | Euro-Celtique S.A. | Pharmaceutical combinations of oxycodone and naloxone |
US6864370B1 (en) * | 2003-06-05 | 2005-03-08 | Zhaiwei Lin | Process for manufacturing oxycodone |
US20050203115A1 (en) * | 2004-03-10 | 2005-09-15 | Sancilio Frederick D. | Narcotic-NSAID ion pairs |
TW201509943A (zh) * | 2004-03-30 | 2015-03-16 | Euro Celtique Sa | 含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
SK286087B6 (sk) | 2004-08-18 | 2008-03-05 | Zentiva, A. S. | Spôsob prípravy oxykodonu |
GB0421149D0 (en) | 2004-09-23 | 2004-10-27 | Johnson Matthey Plc | Preparation of oxycodone |
SK286233B6 (sk) | 2004-11-15 | 2008-05-06 | Zentiva, A. S. | Spôsob izolácie 14-hydroxykodeinonu |
WO2006091885A2 (en) * | 2005-02-24 | 2006-08-31 | Dr Pharma Nova, Llc | A registry method and control system for dea schedule ii-v medicines |
CN101198612A (zh) | 2005-06-16 | 2008-06-11 | 马林克罗特公司 | 通过1-卤代-蒂巴因或类似物制备14-羟基阿片类的合成路线 |
KR100753432B1 (ko) | 2005-11-08 | 2007-08-31 | 경희대학교 산학협력단 | 다결정 실리콘 및 그의 결정화 방법 |
US20070117826A1 (en) * | 2005-11-23 | 2007-05-24 | Forest Laboratories, Inc. | Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone |
JP5695296B2 (ja) | 2006-03-02 | 2015-04-01 | マリンクロッド エルエルシー | 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法 |
JP2010511726A (ja) * | 2006-12-04 | 2010-04-15 | ノランコ・インコーポレーテツド | 14−ヒドロキシコデイノンの濃度が低いオキシコドンの製造方法 |
ES2378710T3 (es) | 2006-12-04 | 2012-04-17 | Noramco, Inc. | Procedimiento para reducir impurezas en la base de oxicodona |
GB0624880D0 (en) | 2006-12-14 | 2007-01-24 | Johnson Matthey Plc | Improved method for making analgesics |
PL2125824T3 (pl) | 2007-03-23 | 2014-05-30 | SpecGx LLC | Ulepszony sposób wytwarzania oksymorfonu z oripawiny |
CA2684458A1 (en) * | 2007-04-16 | 2008-10-30 | Mallinckrodt Inc. | Novel opiate reduction utilizing catalytic hydrogen transfer reaction |
GB2450691A (en) | 2007-07-02 | 2009-01-07 | Alpharma Aps | One-pot preparation of oxycodone from thebaine |
WO2010140636A1 (ja) | 2009-06-03 | 2010-12-09 | 高砂香料工業株式会社 | 不斉水素化触媒 |
US9073934B2 (en) | 2009-09-16 | 2015-07-07 | Monash University | Method for the N-demethylation of N-methyl heterocycles |
EP2377866B1 (en) * | 2010-03-23 | 2014-02-26 | Siegfried AG | Preparation of low impurity opiates in a continuous flow reactor |
EP2580218B1 (en) | 2010-06-11 | 2015-02-25 | Rhodes Technologies | Process for n-dealkylation of tertiary amines |
JP5988272B2 (ja) * | 2010-07-02 | 2016-09-07 | ジョンソン、マッセイ、パブリック、リミテッド、カンパニーJohnson Matthey Public Limited Company | オキシコドンの合成及び精製プロセス |
JP5728084B2 (ja) | 2010-07-08 | 2015-06-03 | アルカーメス ファーマ アイルランド リミテッド | 置換モルフィナンの合成のための方法 |
JP5780933B2 (ja) | 2010-12-01 | 2015-09-16 | 高砂香料工業株式会社 | 光学活性メントールの製造方法 |
CA2870056C (en) | 2012-06-11 | 2021-01-19 | Siegfried Ag | Improved method of preparing oxymorphone |
AU2013291723B2 (en) | 2012-07-16 | 2016-07-28 | Rhodes Technologies | Process for improved opioid synthesis |
CA2879270C (en) | 2012-07-16 | 2017-09-05 | Rhodes Technologies | Process for improved opioid synthesis |
CN103113378B (zh) | 2013-02-20 | 2016-04-06 | 北京华素制药股份有限公司 | 一种盐酸羟吗啡酮的合成方法 |
CN103433076B (zh) | 2013-09-02 | 2015-06-24 | 浙江新和成股份有限公司 | 一种固载型不对称催化剂及其在不对称氢化反应中的应用 |
US9060620B1 (en) | 2013-12-04 | 2015-06-23 | Yogi Realty LLC | Baby restraining article |
US8846923B1 (en) | 2013-12-18 | 2014-09-30 | Cody Laboratories, Inc. | Preparation of 14-hydroxycodeinone sulfate |
WO2015095585A2 (en) | 2013-12-18 | 2015-06-25 | Cody Laboratories, Inc. | Sysnthesis of oxycodone hydrochloride |
US9062062B1 (en) | 2013-12-18 | 2015-06-23 | Cody Laboratories, Inc. | Synthesis of oxycodone hydrochloride |
US10227354B2 (en) | 2013-12-18 | 2019-03-12 | Cody Laboratories, Inc. | Conversion of oxycodone base to oxycodone hydrochloride |
KR101868724B1 (ko) | 2014-01-15 | 2018-06-18 | 로드스 테크놀로지즈 | 개선된 옥시모르폰 합성을 위한 방법 |
AU2015207733A1 (en) | 2014-01-15 | 2016-07-14 | Rhodes Technologies | Process for improved oxycodone synthesis |
-
2013
- 2013-07-15 AU AU2013291723A patent/AU2013291723B2/en active Active
- 2013-07-15 MX MX2015000880A patent/MX362186B/es active IP Right Grant
- 2013-07-15 TW TW105112605A patent/TW201639855A/zh unknown
- 2013-07-15 TW TW102125209A patent/TWI588147B/zh active
- 2013-07-15 EP EP13745177.9A patent/EP2877473B1/en active Active
- 2013-07-15 UA UAA201501304A patent/UA117226C2/uk unknown
- 2013-07-15 CN CN201380037927.6A patent/CN104507947B/zh active Active
- 2013-07-15 ES ES13745177.9T patent/ES2638178T3/es active Active
- 2013-07-15 AR ARP130102526 patent/AR091779A1/es unknown
- 2013-07-15 SG SG11201407986QA patent/SG11201407986QA/en unknown
- 2013-07-15 US US14/413,360 patent/US20150259355A1/en not_active Abandoned
- 2013-07-15 CA CA2879268A patent/CA2879268C/en active Active
- 2013-07-15 EA EA201590221A patent/EA029925B1/ru not_active IP Right Cessation
- 2013-07-15 BR BR112015000867A patent/BR112015000867A2/pt not_active Application Discontinuation
- 2013-07-15 NZ NZ628695A patent/NZ628695A/en unknown
- 2013-07-15 NZ NZ715111A patent/NZ715111A/en unknown
- 2013-07-15 KR KR1020157003909A patent/KR101946104B1/ko active IP Right Grant
- 2013-07-15 WO PCT/IB2013/001538 patent/WO2014013311A1/en active Application Filing
- 2013-07-15 JP JP2015522181A patent/JP6236446B2/ja active Active
-
2015
- 2015-01-13 IL IL236711A patent/IL236711B/en active IP Right Grant
- 2015-01-14 PH PH12015500088A patent/PH12015500088B1/en unknown
- 2015-01-29 CO CO15018246A patent/CO7180189A2/es unknown
- 2015-02-12 IN IN1164DEN2015 patent/IN2015DN01164A/en unknown
- 2015-11-09 HK HK15111025.9A patent/HK1210171A1/xx unknown
-
2016
- 2016-07-14 AU AU2016204929A patent/AU2016204929A1/en not_active Abandoned
-
2017
- 2017-09-11 US US15/700,345 patent/US10202396B2/en active Active
-
2019
- 2019-02-08 US US16/270,969 patent/US20190308986A1/en not_active Abandoned
-
2020
- 2020-09-08 US US17/014,134 patent/US11390627B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500088A1 (en) | Process for improved opioid synthesis | |
PH12015500089A1 (en) | Process for improved opioid synthesis | |
PH12017500281A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
PH12015502615B1 (en) | Chemical compounds | |
TN2015000278A1 (en) | Autotaxin inhibitors | |
PH12015502414A1 (en) | Enhancer of zeste homolog 2 inhibitors | |
GB201118656D0 (en) | New compounds | |
MX366899B (es) | Nuevos compuestos. | |
MX349004B (es) | Nuevos compuestos. | |
MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
WO2013173441A3 (en) | Enhancer of zeste homolog 2 inhibitors | |
PH12015501609A1 (en) | Phenicol antibacterials | |
TW201613864A (en) | Novel compounds | |
IN2015DN02109A (es) | ||
MX2015005510A (es) | Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
MX2013002446A (es) | Derivados de tetrahidropirrolopirazina sustituidos. | |
PH12016501808A1 (en) | Chemical compounds | |
IN2013MU01223A (es) | ||
TN2013000146A1 (en) | Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
IN2013MU01225A (es) | ||
IN2013MU02777A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |